Core Viewpoint - Yiteng Jiahe (06998) has completed a reverse acquisition with Jiahe Biotechnology, marking the official establishment of Yiteng Jiahe and entering a new phase of strategic integration and development [5]. Group 1: Stock Performance - Yiteng Jiahe's stock price rose by 6.04% to HKD 2.81, with an intraday increase exceeding 9% and a trading volume of HKD 9.8047 million [5]. Group 2: Corporate Actions - The reverse acquisition was finalized on December 30, and the Chinese stock abbreviation for Jiahe Biotechnology will change from "嘉和生物" to "亿腾嘉和," effective from February 6, 2026 [5]. - Jiahe Biotechnology announced plans to repurchase shares in the open market, with a total repurchase amount of approximately HKD 18.517 million and 7.245 million shares repurchased as of February 5 [5].
亿腾嘉和午后涨超6% 股份简称今日起正式更名为“亿腾嘉和”